NM_006755.2:c.49C>T
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_006755.2(TALDO1):c.49C>T(p.Gln17*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. Q17Q) has been classified as Likely benign.
Frequency
Consequence
NM_006755.2 stop_gained
Scores
Clinical Significance
Conservation
Publications
- transaldolase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae), Orphanet, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_006755.2. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TALDO1 | TSL:1 MANE Select | c.49C>T | p.Gln17* | stop_gained | Exon 1 of 8 | ENSP00000321259.3 | P37837-1 | ||
| TALDO1 | TSL:1 | c.49C>T | p.Gln17* | stop_gained | Exon 1 of 8 | ENSP00000437098.1 | F2Z393 | ||
| TALDO1 | c.49C>T | p.Gln17* | stop_gained | Exon 1 of 9 | ENSP00000566455.1 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 34
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at